Securing genomic data: Effective cybersecurity strategies for healthcare information systems

Welcome reader to a 🔒 pro subscriber-only deep dive 🔒.

Brought to you by:

👉 Cypago - Cyber governance, risk management, and continuous control monitoring in a single platform

🧠 Ridge Security - The AI-powered offensive security validation platform

Forwarded this email? Join 70,000 weekly readers by signing up now.

#OpenToWork? Try our AI Resume Builder to boost your chances of getting hired!

—

Get lifetime access to our deep dives, weekly cyber intel podcast report, premium content, AI Resume Builder, and more — all for just $799. Corporate plans are now available too.

Executive Summary

Genomic data represents one of the most sensitive categories of healthcare information, presenting unique security challenges due to its permanent and identifying nature. Unlike other forms of personal health information, genomic data cannot be changed if compromised, contains inheritable characteristics affecting family members, and maintains its sensitivity throughout an individual's lifetime and beyond. As genomic sequencing becomes more affordable and widespread in clinical settings, healthcare organizations face increasing responsibility to implement robust cybersecurity strategies that protect this sensitive data while enabling its beneficial use for patient care and research.

This whitepaper examines the most effective cybersecurity strategies for protecting patient genomic data in healthcare information systems as of 2025. Drawing on current research findings and industry best practices, it identifies a multi-layered approach combining technical controls, organizational policies, and emerging technologies. Key protection strategies include encryption at all data states, privacy-preserving computation techniques, advanced access controls, secure infrastructure design, and comprehensive governance frameworks aligned with current regulations.

The recommended approach emphasizes defense-in-depth methodology where multiple security layers work together to provide comprehensive protection. With the continued advancement of technologies like homomorphic encryption, secure multi-party computation, and blockchain-based audit mechanisms, healthcare organizations now have powerful tools to safeguard genomic data while supporting legitimate clinical and research applications.

1. Introduction

1.1 The Unique Nature of Genomic Data

Genomic data represents the most personal of all health information. It contains an individual's complete genetic makeup, revealing information about disease predispositions, ancestral history, and inherited traits. Unlike other forms of personal data, genomic information:

• Is permanent and unchangeable throughout an individual's lifetime

• Reveals information about biological relatives, not just the individual

• Maintains its sensitivity indefinitely, even after a person's death

• Can potentially be used to identify individuals even when supposedly "anonymized"

• May reveal unexpected and sensitive health information as genetic science advances

The falling cost of genomic sequencing has made genetic testing increasingly common in clinical settings. What once cost billions for the first human genome now costs under $200 for whole genome sequencing, resulting in exponential growth in the volume of genomic data being generated, stored, and analyzed in healthcare information systems.

1.2 Current Threat Landscape

Healthcare information systems face a sophisticated and evolving threat landscape. Recent research has identified several critical threats specifically targeting genomic data:

Advanced Persistent Threats (APTs): Nation-state actors have demonstrated interest in genomic datasets, particularly population-level data that could have strategic value. In 2023, multiple genomic research institutions reported sophisticated attacks attributed to state-sponsored threat actors.

Re-identification Attacks: Studies show that supposedly de-identified genomic data can be re-identified with alarming accuracy. Research published in 2024 demonstrated successful re-identification of individuals in anonymized genomic datasets with 83% accuracy when combined with publicly available information.

Ransomware: Healthcare continues to be a primary target for ransomware attacks. In 2024, several genomics laboratories experienced targeted ransomware attacks, with threat actors specifically demanding higher ransoms due to the sensitive nature of the genomic data involved.

Internal Threats: Inappropriate access by authorized users remains a significant concern. A 2023 survey of healthcare security incidents found that 32% of genomic data breaches resulted from improper access by authorized personnel rather than external attacks.

Synthetic DNA and Sequencing Vulnerabilities: Recent demonstrations have shown that maliciously crafted synthetic DNA could potentially be used to compromise sequencing systems, highlighting new attack vectors unique to genomic workflows.

1.3 Regulatory Landscape

The regulatory environment governing genomic data protection continues to evolve:

HIPAA and HITECH: In the United States, genomic data is classified as Protected Health Information (PHI) when handled by covered entities and their business associates, requiring compliance with the HIPAA Security Rule.

GINA (Genetic Information Nondiscrimination Act): Prohibits discrimination based on genetic information for health insurance and employment purposes, though it doesn't directly address security requirements.

GDPR: The European Union's General Data Protection Regulation classifies genetic data as a "special category" of personal data requiring enhanced protection measures and explicit consent.

China's PIPL: China's Personal Information Protection Law, which went into effect in 2021, specifically categorizes genomic data as "sensitive personal information" requiring additional protections.

Emerging Standards: The International Standards Organization (ISO) published ISO/TS 22690:2024, specifically addressing security and privacy requirements for genomic information.

This paper presents a comprehensive framework for protecting genomic data in healthcare information systems, addressing technical, organizational, and procedural aspects of security.

2. Technical Cybersecurity Strategies

2.1 Encryption and Data Protection

Encryption serves as a foundational control for protecting genomic data. Current best practices include implementing encryption at all three states of data:

2.1.1 Encryption at Rest

Full Database Encryption: All genomic databases should implement transparent data encryption (TDE) with strong algorithms (AES-256 or higher). This protects against unauthorized access to raw database files and storage media.

File-Level Encryption: Genomic files (FASTQ, BAM, VCF) should be encrypted with unique keys, providing an additional layer of protection beyond database encryption.

Storage Medium Encryption: Full-disk encryption should be implemented on all storage systems containing genomic data, including backup media.

Key Management: Hardware Security Modules (HSMs) should be used to securely store and manage encryption keys, with strict access controls and key rotation policies.

Research by Fujiwara et al. (2022) demonstrated that one-time pad encryption with quantum key distribution can achieve throughputs exceeding 400 Mbps with information-theoretic security guarantees for genomic data.

2.1.2 Encryption in Transit

Transport Layer Security (TLS): All network transmissions of genomic data should use TLS 1.3 or later with strong cipher suites. Self-signed certificates should be avoided.

End-to-End Encryption: When sharing genomic data between organizations, end-to-end encryption should be implemented, ensuring data remains encrypted throughout the communication path.

VPN for Remote Access: Any remote access to systems containing genomic data should occur over encrypted VPN connections with multi-factor authentication.

2.1.3 Encryption in Use

Emerging technologies now enable computation on encrypted data, addressing a previously significant gap in protection:

Homomorphic Encryption (HE): Enables computation on encrypted genomic data without decryption. While fully homomorphic encryption (FHE) has historically been computationally intensive, recent advances have made it increasingly practical for genomic applications.

A 2025 study by Raisaro et al. demonstrated that homomorphic encryption can enable secure computation of basic statistics on over 3,000 encrypted genetic variants in less than 5 seconds for a cohort of 5,000 individuals.

Secure Enclaves: Technologies like Intel SGX and AMD SEV create protected execution environments where genomic data can be processed in memory while remaining encrypted and inaccessible to the underlying operating system.

Confidential Computing: Cloud providers now offer confidential computing services that encrypt data in use, enabling secure processing of genomic data in cloud environments.

2.2 Privacy-Preserving Computation

Several advanced techniques now enable analysis of genomic data while minimizing privacy risks:

2.2.1 Differential Privacy

Differential privacy adds calibrated noise to query results, mathematically limiting what can be learned about any individual while maintaining the utility of aggregate results. This approach is particularly valuable for genomic data analysis and has been successfully implemented in several large-scale genomic studies.

The Genomic Privacy Protection Framework, released in 2024, provides tools for implementing differential privacy specifically tailored to common genomic analysis workflows.

2.2.2 Secure Multi-Party Computation (SMPC)

SMPC enables multiple parties to jointly analyze their genomic datasets without revealing the underlying data to each other. This approach is particularly valuable for cross-institutional research collaboration.

A notable 2024 implementation by Jagadeesh et al. demonstrated secure identification of causal variants in Mendelian diseases across multiple institutions with protection quotients ranging from 97.1% to 99.7%.

2.2.3 Federated Analysis

Federated learning and analysis approaches train models or perform analysis locally at each participating institution, sharing only the derived models or aggregate results rather than raw genomic data.

These techniques have been successfully implemented in several international genomic collaborations, enabling research that would otherwise be impossible due to data sharing restrictions.

2.3 Advanced Access Controls

Protecting genomic data requires sophisticated access control mechanisms beyond traditional models:

2.3.1 Attribute-Based Access Control (ABAC)

ABAC evaluates multiple attributes (user role, data sensitivity, context, purpose) against policies to determine access permissions. This approach enables fine-grained control over genomic data access based on factors like:

• Specific genes or regions being accessed

• Analysis purpose (clinical care vs. research)

• Level of data aggregation

• Patient consent parameters

2.3.2 Purpose-Based Access Control

Purpose-based access control explicitly links access permissions to the purpose for which the data will be used, aligning with both ethical principles and regulatory requirements. Modern genomic data management systems now include:

• Purpose specification during access requests

• Automated validation against consent parameters

• Purpose enforcement through technical controls

• Comprehensive audit trails of purpose declarations and actual usage

2.3.3 Dynamic Consent Management

Modern consent management systems enable patients to specify granular permissions for their genomic data and modify these permissions over time:

• Opt-in/opt-out for specific research purposes

• Time limitations on access permissions

• Restrictions on data types that can be accessed

• Revocation capabilities with technical enforcement

These systems must be tightly integrated with access control mechanisms to ensure technical enforcement of consent parameters.

Subscribe to CybersecurityHQ Newsletter to unlock the rest.